AI Science Tracker
EN

The First Clinical Medical School of Lanzhou University

1 discovery from 2023

Discoveries

Development and validation of a nomogram model for lung cancer based on radiomics artificial intelligence score and clinical blood test data

Source check: Source checked. Not independent scientific confirmation.

Finding: The combined model reported AUC 0.907 in development and 0.844 in external validation. This record is limited to the study result and does not establish independent replication or real-world benefit.

Technology: LASSO and Random Forest

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
ML feature selection generated an AI/radiomics score combined with clinical blood-test variables in a lung-cancer nomogram.
Test and result
The combined model reported AUC 0.907 in development and 0.844 in external validation.
Limitation / still unknown
The source-checked evidence does not establish broader external validity or prospective benefit. Affiliation was not available in the retrieved trusted primary metadata.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2023.1132514/full · https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2023.1132514/full#s2 · https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2023.1132514/full#s3–s4 · https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2023.1132514/full#s2–s4

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open the interactive profile for the timeline, or browse all organizations and model families.